Details for New Drug Application (NDA): 209700
✉ Email this page to a colleague
NDA 209700 describes TERIFLUNOMIDE, which is a drug marketed by Accord Hlthcare, Alembic, Amneal Pharms Co, Apotex, Aurobindo Pharma, Biocon Pharma, Breckenridge, Glenmark Pharms, Hetero Labs Ltd V, MSN, Mylan, Natco, Sandoz, Sola Pharms, Teva Pharms Usa, Watson Labs Teva, and Zydus Pharms, and is included in seventeen NDAs. It is available from twenty-one suppliers. Additional details are available on the TERIFLUNOMIDE profile page.
The generic ingredient in TERIFLUNOMIDE is teriflunomide. There are nineteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the teriflunomide profile page.
The generic ingredient in TERIFLUNOMIDE is teriflunomide. There are nineteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the teriflunomide profile page.
Summary for 209700
| Tradename: | TERIFLUNOMIDE |
| Applicant: | Teva Pharms Usa |
| Ingredient: | teriflunomide |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 209700
| Mechanism of Action | Dihydroorotate Dehydrogenase Inhibitors |
Suppliers and Packaging for NDA: 209700
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209700 | ANDA | Teva Pharmaceuticals, Inc. | 0480-3156 | 0480-3156-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-3156-56) |
| TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209700 | ANDA | Teva Pharmaceuticals, Inc. | 0480-3157 | 0480-3157-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-3157-56) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 7MG | ||||
| Approval Date: | Sep 4, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 14MG | ||||
| Approval Date: | Sep 4, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
